Shivom - World Healthcare Based on Blockchain

christoperlambe (25)in #altcoin • 6 years ago

All human genes, now successfully investigated. The next program is to analyze gene function and mapping the relationship of genes to each other. This analysis is very useful to recognize more about the normal process of biochemistry and physiology that occurs in the body. In addition, this analysis will also help humans to recognize the pathological state of a person and can estimate the process of response to the presence of external stimuli, such as the provision of drugs. Understanding of the health system based on genomic analysis is then gave birth to a new discipline called Pharmacogenomics, while one of the main technologies used for its development is DNA microarray. The development of the pharmacogenomic science will usher in a new paradigm in a treatment system called "individual medicine".

Currently a major program is being undertaken by scientists in the field of molecular biology incorporated in the Human Genome Project (HGP) (http://www.ornl.gov/hgmis), which is a complete mapping of all genes held by humans. The program was originally planned to be completed in 2005, but thanks to the development of science and techniques in the field of rapid molecular biology, the program has been completed more quickly than its schedule. Together with Celera (http://www.celera.com), a competitor in this genome project, HGP announced its sequel results on June 16, 2000 at the White House, Washington. Thus, all of the 100,000 human genes are identifiable. The next program is to perform functional analysis and mapping relationships with each other. It is hard to imagine how to make possible connections from such elements. This will be an interesting picture, because it happens in the human body making it possible for humans to better understand in detail the events that occur in their bodies. Therefore it is not excessive if the program is said to be an ambitious program that is being worked on by humans beginning this century. In addition, following the success of the genome sequencing program, an individual genetic diversity analysis program called Single Nucleotide Polymorphism (SNP) (http://www.snps.com or http://www.ncbi.nlm.nih.gov/ SNP).

The success of the program will have an enormous impact on human life, it may even be wider than expected at present. The reason is that the product of the program will provide complete data on the characteristic of human origin stored in the mapped genes. Complete data of genes or genomic data will unveil the entire biochemical processes that occur in the human body that affect its properties. A complete knowledge of the processes occurring within the human body will be able to change the paradigm in the sciences related to humans in the health sciences. The development is also expected to be applied to technological developments such as blockchain. If applied to blockchain it will reduce the cost associated with data storage characteristics of individual genes. It may also be used by other agencies if the owner is willing. The agency can be a pharmaceutical company, research even state or government. Currently there is a project that is trying to create a genome ecosystem with a blockchain base that is Shivom.

Shivom

Shivom is a blockchain-based platform that records the characteristics of individual genes and treatments that can be applied to the characteristics of the gene. Shivom ensures that the data owned is safe because it is owned by the donor itself. This ensures a transparent and secure bridge for organizations interested in using the data. The shivom platform can work using Omix Token.

The OmiX Token

The OmiX token is a key component that enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system.

• Ability to acquire premium services in the Shivom ecosystem

• Ability to acquire genome sequencing kits

• Ability to sponsor sequencing projects

• Ability to acquire access to health/fitness apps from 3rd party providers

• Ability to access the genome database

• Ability to pay donors for data/participation in research studies

• Ability for service providers to use the platform